Skip to main content
. 2018 Jan 16;8:1993. doi: 10.3389/fimmu.2017.01993

Figure 2.

Figure 2

Adoptive cell therapy and murine cytomegalovirus (MCMV)-OVA vaccination cures mice of B16ova. Wild-type (WT) mice were challenged with B16ova i.d. and 8 days later were left untreated, treated with 105 OT-I cells i.v., treated with 105 PFU MCMV-OVA i.p., treated with OT-I transfer i.v. and 105 PFU WT MCMV i.p., or treated with OT-I transfer i.v. and MCMV-OVA i.p. (A) Tumor growth curves of individual mice treated as shown. (B) Survival curves for experiment shown in (A). n = 5 mice. Number of tumor-free mice at end of experiment shown in (A). Data are representative of three independent experiments. ***p < 0.001.